These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16362634)

  • 21. Multiple system atrophy: laminar distribution of the pathological changes in frontal and temporal neocortex--a study in ten patients.
    Armstrong RA; Lantos PL; Cairns NJ
    Clin Neuropathol; 2005; 24(5):230-5. PubMed ID: 16167547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A quantitative study of the pathological changes in ten patients with multiple system atrophy (MSA).
    Armstrong RA; Cairns NJ; Lantos PL
    J Neural Transm (Vienna); 2004 Apr; 111(4):485-95. PubMed ID: 15057518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurodegeneration with features of NIFID and ALS--extended clinical and neuropathological spectrum.
    Roeber S; Bäzner H; Hennerici M; Porstmann R; Kretzschmar HA
    Brain Pathol; 2006 Jul; 16(3):228-34. PubMed ID: 16911480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A quantitative study of the pathological changes in the cortical white matter in variant Creutzfeldt-Jakob disease (vCJD).
    Armstrong RA
    Clin Neuropathol; 2010; 29(6):390-6. PubMed ID: 21073844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and pathological heterogeneity of neuronal intermediate filament inclusion disease.
    Molina-Porcel L; Lladó A; Rey MJ; Molinuevo JL; Martinez-Lage M; Esteve FX; Ferrer I; Tolosa E; Blesa R
    Arch Neurol; 2008 Feb; 65(2):272-5. PubMed ID: 18268200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for neurofilament inclusion disease using alpha-internexin immunohistochemistry.
    Uchikado H; Shaw G; Wang DS; Dickson DW
    Neurology; 2005 May; 64(9):1658-9. PubMed ID: 15883343
    [No Abstract]   [Full Text] [Related]  

  • 27. Ubiquitin-positive neuronal and tau 2-positive glial inclusions in frontotemporal dementia of motor neuron type.
    Forno LS; Langston JW; Herrick MK; Wilson JD; Murayama S
    Acta Neuropathol; 2002 Jun; 103(6):599-606. PubMed ID: 12012092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NIFID: a new molecular pathology with a frontotemporal dementia phenotype.
    DeKosky ST; Ikonomovic MD
    Neurology; 2004 Oct; 63(8):1348-9. PubMed ID: 15505145
    [No Abstract]   [Full Text] [Related]  

  • 29. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation.
    Shi J; Shaw CL; Du Plessis D; Richardson AM; Bailey KL; Julien C; Stopford C; Thompson J; Varma A; Craufurd D; Tian J; Pickering-Brown S; Neary D; Snowden JS; Mann DM
    Acta Neuropathol; 2005 Nov; 110(5):501-12. PubMed ID: 16222525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A quantitative study of the pathological lesions in the neocortex and hippocampus of twelve patients with corticobasal degeneration.
    Armstrong RA; Cairns NJ; Lantos PL
    Exp Neurol; 2000 Jun; 163(2):348-56. PubMed ID: 10833308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuronal and glial tau pathology in early frontotemporal lobar degeneration-tau, Pick's disease subtype.
    Mimuro M; Yoshida M; Miyao S; Harada T; Ishiguro K; Hashizume Y
    J Neurol Sci; 2010 Mar; 290(1-2):177-82. PubMed ID: 20022024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortical ubiquitin-positive inclusions in frontotemporal dementia without motor neuron disease: a quantitative immunocytochemical study.
    Kövari E; Gold G; Giannakopoulos P; Bouras C
    Acta Neuropathol; 2004 Sep; 108(3):207-12. PubMed ID: 15170577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple system atrophy (MSA): topographic distribution of the alpha-synuclein-associated pathological changes.
    Armstrong RA; Cairns NJ; Lantos PL
    Parkinsonism Relat Disord; 2006 Sep; 12(6):356-62. PubMed ID: 16723266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinico-pathological investigation of two patients with dementia with motor neuron disease].
    Yamamoto R; Iseki E; Murayama N; Minegishi M; Kimura M; Eto K; Arai H; Ohbu S; Hatanaka D; Hino H; Fujisawa K
    Brain Nerve; 2007 Mar; 59(3):263-9. PubMed ID: 17370652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gigaxonin mutation analysis in patients with NIFID.
    Dequen F; Cairns NJ; Bigio EH; Julien JP
    Neurobiol Aging; 2011 Aug; 32(8):1528-9. PubMed ID: 19782434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of pathological lesions in the frontal and temporal lobe of ten patients diagnosed with Pick's disease.
    Armstrong RA; Cairns NJ; Lantos PL
    Acta Neuropathol; 1999 May; 97(5):456-62. PubMed ID: 10334482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. α-Internexin and Peripherin: Expression, Assembly, Functions, and Roles in Disease.
    Zhao J; Liem RK
    Methods Enzymol; 2016; 568():477-507. PubMed ID: 26795481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laminar distribution of the pathological changes in frontal and temporal cortex in 8 patients with progressive supranuclear palsy.
    Armstrong RA; Cairns NJ
    Clin Neuropathol; 2009; 28(5):350-7. PubMed ID: 19788050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex.
    Hof PR; Cox K; Morrison JH
    J Comp Neurol; 1990 Nov; 301(1):44-54. PubMed ID: 2127598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. alpha-Internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the beta-amyloid plaques in inducing neuronal injury.
    Dickson TC; Chuckowree JA; Chuah MI; West AK; Vickers JC
    Neurobiol Dis; 2005 Mar; 18(2):286-95. PubMed ID: 15686957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.